Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM50067499 ((6aR,10aR)-3(1,1-dimethylheptyl)-9-hydroxymethyl)-...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet  | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | 2.94 | -49.5 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235935 (US9365534, HU-910) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 6 | -47.7 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50117099 (CHEMBL3613118 | US9365534, HU-308) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem | US Patent | 14 | -45.6 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235934 (US9365534, HU-909) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 56.8 | -42.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235937 (US9365534, HU-912) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 77.1 | -41.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235938 (US9365534, HU-913) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 81.5 | -41.1 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235936 (US9365534, HU-911) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 84.6 | -41.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235940 (US9365534, HU-926) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 106 | -40.5 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235947 (US9365534, HU-972) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 168 | -39.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235941 (US9365534, HU-928) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 230 | -38.5 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235946 (US9365534, HU-971) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 704 | -35.7 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235948 (US9365534, HU-973) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.15E+3 | -34.5 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235945 (US9365534, HU-970) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.27E+3 | -34.2 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM235935 (US9365534, HU-910) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.37E+3 | -34.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235939 (US9365534, HU-914) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.50E+3 | -33.8 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235942 (US9365534, HU-936) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.72E+3 | -33.5 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235933 (US9365534, HU-907) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.51E+3 | -32.5 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235944 (US9365534, HU-969) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 6.46E+3 | -30.1 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235943 (US9365534, HU-938) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 7.91E+3 | -29.6 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235949 (US9365534, HU-974) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | >1.00E+4 | >-29.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM235937 (US9365534, HU-912) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | >1.00E+4 | >-29.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM235934 (US9365534, HU-909) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.17E+4 | -28.6 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50117099 (CHEMBL3613118 | US9365534, HU-308) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem | US Patent | n/a | n/a | 117 | n/a | n/a | n/a | n/a | 7.5 | 37 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235935 (US9365534, HU-910) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 162 | n/a | n/a | n/a | n/a | 7.5 | 37 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235937 (US9365534, HU-912) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 239 | n/a | n/a | n/a | n/a | 7.5 | 37 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235947 (US9365534, HU-972) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 313 | n/a | n/a | n/a | n/a | 7.5 | 37 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235940 (US9365534, HU-926) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 321 | n/a | n/a | n/a | n/a | 7.5 | 37 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235938 (US9365534, HU-913) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 330 | n/a | n/a | n/a | n/a | 7.5 | 37 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235936 (US9365534, HU-911) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 385 | n/a | n/a | n/a | n/a | 7.5 | 37 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235934 (US9365534, HU-909) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 425 | n/a | n/a | n/a | n/a | 7.5 | 37 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235941 (US9365534, HU-928) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 925 | n/a | n/a | n/a | n/a | 7.5 | 37 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235945 (US9365534, HU-970) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.15E+3 | n/a | n/a | n/a | n/a | 7.5 | 37 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235946 (US9365534, HU-971) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.53E+3 | n/a | n/a | n/a | n/a | 7.5 | 37 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235948 (US9365534, HU-973) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.09E+3 | n/a | n/a | n/a | n/a | 7.5 | 37 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235939 (US9365534, HU-914) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.29E+3 | n/a | n/a | n/a | n/a | 7.5 | 37 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM235937 (US9365534, HU-912) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.37E+3 | n/a | n/a | n/a | n/a | 7.5 | 37 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50117099 (CHEMBL3613118 | US9365534, HU-308) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 18.3 | n/a | n/a | 7.5 | n/a |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235940 (US9365534, HU-926) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 185 | n/a | n/a | 7.5 | n/a |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235938 (US9365534, HU-913) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 344 | n/a | n/a | 7.5 | n/a |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235936 (US9365534, HU-911) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 126 | n/a | n/a | 7.5 | n/a |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235941 (US9365534, HU-928) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 577 | n/a | n/a | 7.5 | n/a |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235934 (US9365534, HU-909) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 136 | n/a | n/a | 7.5 | n/a |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235935 (US9365534, HU-910) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 26.4 | n/a | n/a | 7.5 | n/a |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
